Tg(Fev-cre/ERT2)aEsd
Transgene Detail
|
Symbol: |
Tg(Fev-cre/ERT2)aEsd |
Name: |
transgene insertion a, Evan S Deneris |
MGI ID: |
MGI:4837204 |
Synonyms: |
ePet::CreERT2ascend |
Transgene: |
Tg(Fev-cre/ERT2)aEsd Location: unknown
|
Alliance: |
Tg(Fev-cre/ERT2)aEsd page
|
|
Strain of Origin: |
C57BL/6 x 129
|
|
Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Tg(Fev-cre/ERT2)aEsd expression driven by
1 gene
Transgene expression driven by:
Organism |
Driver Gene |
Note |
Not Specified |
Fev |
|
|
|
|
Mutation details: A 40 kb genomic fragment of Fev enhancer sequence and a beta-globin minimal promoter drive expression a fusion gene of cre and a mutant human estrogen receptor. This transgene also contains beta-globin intron and simian virus 40 polyadenylation sequences. After tamoxifen treatment this line shows recombination in up to 80% of the serotonergic neurons in the dorsal Raphe nucleus (B6, B7) the medial Raphe nucleus (B5, B8) and B9 nucleus. Minimal recombination is seen in the medullary nuclei (B1-B3).
(J:165266)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Fev
(species not specified)
|
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:165266 Liu C, et al., Pet-1 is required across different stages of life to regulate serotonergic function. Nat Neurosci. 2010 Oct;13(10):1190-8 |
All: |
1 reference(s) |
|